Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor

Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues

(2020) Nagamine et al.   Diagnostics

Cancer-Associated Mutations in Endometriosis without Cancer

(2017) Michael S. Anglesio et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mismatch Repair Protein Expression in Clear Cell Carcinoma of the Ovary

(2016) Jennifer A. Bennett et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The molecular pathology of ovarian serous borderline tumors

(2016) A. Malpica et al.   ANNALS OF ONCOLOGY

Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology

(2016) Angel Chao et al.   GYNECOLOGIC ONCOLOGY

Long-term survival of patients with mismatch repair protein-deficient, high-stage ovarian clear cell carcinoma

(2016) Colin J R Stewart et al.   HISTOPATHOLOGY

Seromucinous Tumors of the Ovary. What’s in a Name?

(2016) Robert J. Kurman et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria

(2016) Steffen Hauptmann et al.   VIRCHOWS ARCHIV

Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer

(2016) Angel Chao et al.   Oncotarget

Ovarian Seromucinous Carcinoma

(2015) Jennifer Taylor et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms

(2015) Robertson Mackenzie et al.   BMC CANCER

Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary

(2014) Koah R. Vierkoetter et al.   GYNECOLOGIC ONCOLOGY

Endometrial Carcinomas With Significant Mucinous Differentiation Associated With Higher Frequency of K-ras Mutations

(2013) Jinjun Xiong et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy

(2013) Ren-Chin Wu et al.   JOURNAL OF PATHOLOGY

Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles

(2013) Melissa K McConechy et al.   MODERN PATHOLOGY

Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: Correlation with KRAS mutation and the presence of endometriosis

(2013) Colin J.R. Stewart et al.   PATHOLOGY

Endocervical-type Mucinous Borderline Tumors are Related to Endometrioid Tumors Based on Mutation and Loss of Expression of ARID1A

(2012) Chen Hsuan Wu et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma

(2011) Sohei Yamamoto et al.   JOURNAL OF PATHOLOGY

Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation

(2010) Kyu-Rae Kim et al.   HISTOPATHOLOGY

ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas

(2010) Kimberly C. Wiegand et al.   NEW ENGLAND JOURNAL OF MEDICINE

Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

(2010) Siân Jones et al.   SCIENCE

Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma

(2009) Kuan-Ting Kuo et al.   AMERICAN JOURNAL OF PATHOLOGY

Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors

(2009) Masafumi Yasunaga et al.   HUMAN PATHOLOGY